These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32938553)

  • 61. Pylorus-preserving total pancreatectomy for an intraductal papillary-mucinous neoplasm of the pancreas.
    Inagaki M; Obara M; Kino S; Goto J; Suzuki S; Ishizaki A; Tanno S; Kohgo Y; Tokusashi Y; Miyokawa N; Kasai S
    J Hepatobiliary Pancreat Surg; 2007; 14(3):264-9. PubMed ID: 17520201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Intraductal papillary mucinous neoplasm of the pancreas, IPMN].
    Sirén J
    Duodecim; 2013; 129(6):591-8. PubMed ID: 23614224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pancreatic tumor:progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm(MCN); 5. Management and diagnosis and therapeutic strategies for intraductal papillary mucinous neoplasm of the pancrea : IPMN].
    Kimura W; Takasu N; Murayama S
    Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):79-92. PubMed ID: 22413465
    [No Abstract]   [Full Text] [Related]  

  • 65. [The Laparoscopic Enucleation for Branch Duct Type Intraductal Papillary Mucinous Neoplasms Located at the Body of Pancreas: A Case Report].
    Stevanović D; Stojanović D; Mitrović N; Jašarović D; Milenković S; Bokun-Vukašinović Z; Radovanović D
    Srp Arh Celok Lek; 2015; 143(5-6):332-6. PubMed ID: 26259409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Malignancy predictive factors in pancreatic intraductal papillary mucinous neoplasm].
    Adet Caldelari AC; Miquel R; Bombi JA; Ginés A; Fernández-Esparrach G; Ayuso JR; Maurel J; Feu F; Castells A; Fernández-Cruz L; Navarro S
    Med Clin (Barc); 2011 Nov; 137(14):631-6. PubMed ID: 21414642
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intraductal papillary mucinous neoplasms of the pancreas: indication, extent, and results of surgery.
    Sauvanet A
    Surg Oncol Clin N Am; 2008 Jul; 17(3):587-606, ix. PubMed ID: 18486885
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts.
    Salvia R; Partelli S; Crippa S; Landoni L; Capelli P; Manfredi R; Bassi C; Pederzoli P
    Am J Surg; 2009 Nov; 198(5):709-14. PubMed ID: 19887201
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas].
    Oh SJ; Lee SJ; Lee HY; Paik YH; Lee DK; Lee KS; Chung JB; Yu JS; Yoon DS
    Korean J Gastroenterol; 2009 Sep; 54(3):162-6. PubMed ID: 19844152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
    Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y
    Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical features and prognosis of intraductal papillary mucinous neoplasms of pancreas: analysis of 38 cases].
    Lou WH; Wang DS; Ji Y; Xu XF; Kuang TT; Ni XL; Wu WC; Jin DY
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):947-50. PubMed ID: 16759531
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
    Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
    Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
    Tanaka M
    Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
    Distler M; Welsch T; Aust D; Weitz J; Grützmann R
    Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.
    Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Kanemitsu Y; Sano T; Senda Y; Bhatia V; Yanagisawa A
    Pancreas; 2015 Apr; 44(3):459-64. PubMed ID: 25423557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical criteria for integrated molecular pathology in intraductal papillary mucinous neoplasm: less is more.
    Simpson RE; Cockerill NJ; Yip-Schneider MT; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Al-Haddad MA; Schmidt CM
    HPB (Oxford); 2019 May; 21(5):574-581. PubMed ID: 30293868
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.
    Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Signet-ring Cell Carcinoma Derived from a Main Duct-type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Case Report with Long-term Follow-up.
    Sakai T; Koshita S; Ito K; Kanno Y; Ogawa T; Kusunose H; Masu K; Kawakami Y; Fujii Y; Murabayashi T; Hasegawa S; Kozakai F; Noda Y; Oikawa M; Tsuchiya T; Sawai T
    Intern Med; 2018 Apr; 57(8):1093-1099. PubMed ID: 29269677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.